Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Effectiveness of Depo Provera by Lay vs Clinical Workers in Pakistan
NCT03255941Phase 1Completed
- Sponsor
- FHI 360
- Start
- Mar 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of medroxyprogesterone acetate in contraception (4 arms), sponsored by FHI 360. Primary endpoints: Number of Participants That Were Appropriately Screened for Contraceptive Use at 3 months and Number of Participants That Were Appropriately Counseled for DMPA Use at 3 months. Started Mar 2018; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03255941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255941.